Levels of increased vimentin and decreased E-cadherin were correlated with the L1CAM knockdown effectiveness of shRNA, revealing an undescribed mechanism of the L1CAM on prostate cancer metastasis that contradicts its known function of promoting the EMT seen in other cancer types. Here, L1CAM is linked to prostate cancer.